I have to disagree. The time and sensitivity study

I have to disagree. The time and sensitivity study has been mentioned by NanoLogix as the next required step for clinical use of the N-Assay. For other uses, there's no such requirement but the technology still has to catch the attention of potential users. The CAOG presentation was for bacteria found in pregnancies, not in quality control or environmental situations. The upcoming Ecoli poster presentation at the New Orleans ASM is something quite different BECAUSE Ecoli is a problem across a broad spectrum. Don't blame NanoLogix or its CEO for how long it takes to have presentations accepted. That's a selective complicated process. I'll wager they're very excited about ASM and AACC. The latter is truly the big time and the ASM is significant. It's all about getting the right information in front of decision makers. Those decision makers don't care about NanoLogix shareholder wants and needs. They want results that can demonstrate improved metrics and economics.

The reaction of bashers and manipulators in driving down share price since Friday's announcement ought to make it obvious that they're upset at the positive developments. It's mind blowing that professed longs are helping to depress the price with their blather. BB didn't do this, he didn't do that...

What if he hadn't done anything?

Scott